Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$48.99 - $57.46 $123,993 - $145,431
2,531 New
2,531 $127,000
Q1 2022

Apr 07, 2022

SELL
$48.48 - $53.65 $201,531 - $223,023
-4,157 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$49.36 - $54.25 $13,327 - $14,647
-270 Reduced 6.1%
4,157 $219,000
Q1 2021

May 03, 2021

SELL
$45.46 - $50.51 $15,911 - $17,678
-350 Reduced 7.33%
4,427 $219,000
Q4 2020

Feb 02, 2021

SELL
$45.3 - $51.62 $38,052 - $43,360
-840 Reduced 14.95%
4,777 $232,000
Q2 2020

Oct 07, 2020

SELL
$42.91 - $52.5 $5,578 - $6,825
-130 Reduced 2.26%
5,617 $287,000
Q1 2020

Oct 07, 2020

SELL
$38.02 - $51.66 $57,030 - $77,490
-1,500 Reduced 20.7%
5,747 $251,000
Q4 2019

Feb 13, 2020

SELL
$44.25 - $50.86 $103,766 - $119,266
-2,345 Reduced 24.45%
7,247 $364,000
Q3 2019

Oct 30, 2019

SELL
$40.34 - $46.64 $13,070 - $15,111
-324 Reduced 3.27%
9,592 $444,000
Q2 2019

Aug 06, 2019

SELL
$40.43 - $44.3 $260,975 - $285,956
-6,455 Reduced 39.43%
9,916 $429,000
Q1 2019

Apr 25, 2019

BUY
$40.83 - $45.43 $160,053 - $178,085
3,920 Added 31.48%
16,371 $725,000
Q4 2018

Jan 14, 2019

SELL
$41.48 - $45.59 $77,277 - $84,934
-1,863 Reduced 13.02%
12,451 $540,000
Q3 2018

Oct 09, 2018

SELL
$40.0 - $44.84 $104,400 - $117,032
-2,610 Reduced 15.42%
14,314 $639,000
Q2 2018

Jul 26, 2018

SELL
$37.63 - $41.22 $31,421 - $34,418
-835 Reduced 4.7%
16,924 $677,000
Q1 2018

Apr 10, 2018

SELL
$38.98 - $45.76 $7,990 - $9,380
-205 Reduced 1.14%
17,759 $712,000
Q4 2017

Feb 08, 2018

SELL
$42.86 - $50.61 $260,074 - $307,101
-6,068 Reduced 25.25%
17,964 $772,000
Q3 2017

Nov 07, 2017

SELL
$47.04 - $50.34 $393,254 - $420,842
-8,360 Reduced 25.81%
24,032 $1.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
32,392
32,392 $1.55 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.